Skip to content
healthcare.dev

Nintedanib Capsules, 100 mg and 150 mg

NDC 76282-786, Nintedanib, capsule, from EXELAN PHARMACEUTICALS INC..

Product NDC
76282-786
Status
Listed
Labeler
EXELAN PHARMACEUTICALS INC.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212609
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-786 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NINTEDANIB ESYLATE100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
76282-786-607628207866060 CAPSULE in 1 BOTTLE (76282-786-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/60d8104e-cb6c-4f4f-8159-95ed57346ffa

Use it

Look up 76282-786 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-786 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-786. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.